Research News and Research

RSS

GenVec announces discontinuation of TNFerade PACT trial for pancreatic cancer

GenVec, Inc. announced today that it is discontinuing its Phase 3 clinical trial of TNFerade™ in patients with locally advanced pancreatic cancer based on results of an interim analysis. This interim analysis of overall survival, conducted after the 184th death (two-thirds of total expected events), was designed to determine whether the study should continue.

30 Mar 2010

Conference on the actions of Vitamin D on human health

An important conference on the actions of Vitamin D on human health is being hosted by Barts and The London Medical School and the MRC Asthma UK Centre in Allergic Mechanisms of Asthma.

30 Mar 2010

Researchers to study health literacy among Indigenous people living with cardiovascular disease

Researchers at St. Michael's Hospital in Toronto are part of an international team of researchers recently awarded a multi-million dollar grant for their work in cardiovascular disease among Indigenous people in Canada, Australia and New Zealand. The Canadian team will receive $742,000 in funding for its part of the project from the Canadian Institutes of Health Research and International Collaborative Indigenous Health Research Partnerships.

30 Mar 2010

Shinseki tries to squelch rumors about health reform and Vets

Secretary of Veterans Affairs Erik Shinseki "addressed fears that some veterans have expressed that their health care and, specifically, their TRICARE medical coverage will be adversely affected by the health-reform legislation," according to the Providence Journal.

30 Mar 2010

Health industry will see more patients with reform; Physicians give mixed reviews

The Atlanta Journal-Constitution: "The health care plan aims to send a wave of paying patients to hospitals, doctors and pharmacists." Expanded coverage will mean less uncompensated care, a boon to traditional safety-net hospitals, but also more Medicaid patients. Hospitals say Medicaid fees don't cover their costs, so that influx could hurt the bottom line.

30 Mar 2010

Democrats reflect on importance of reconciliation in health bill strategy

Reconciliation proved critical to health care reform passage, The New York Times reports: "Just a few months into his first term in 1993, President Bill Clinton went to Senator Robert C. Byrd of West Virginia, the protector of Senate rules, to ask permission to use a fast-track budget process known as reconciliation to enact a bold health care overhaul.' At that time, Clinton got neither consent nor the passage of a health care law.

30 Mar 2010

Alcon acquires right to market DUREZOL ophthalmic corticosteroid in U.S.

Alcon, the world's leader in eye care, announced today that it received regulatory approval and finalized the acquisition of the rights in the United States for DUREZOL™ emulsion and the global rights, excluding Latin America, for ZYCLORIN™ from Sirion Therapeutics, Inc.

30 Mar 2010

Industry groups, lobbying firms gain from health overhaul

The Associated Press: Under the new health care law, "pharmaceutical lobbyists won new federal policies they coveted and set a trajectory for long-term industry growth." Ramsey Baghdadi, a Washington health policy analyst, "projects a $30 billion, 10-year net gain for the industry. 'I don't see how they could have done much better,'" he said.

29 Mar 2010

Cutting off coverage? An examination of a case in California

The Huffington Post Investigative Fund on the case of Heather Galeotti, a woman in a coma after being hit by a car: "[I]n July 2007, five months into Galeotti's treatment, Kaiser [Permanente] stunned the family with a letter. The Galeottis would have to find another way to pay the bills. Based on information received from her father's employer, Kaiser said that the young woman's coverage had not been in effect when she was hit."

29 Mar 2010

National Institute of Mental Health awards two-year, $998,940 grant for autism research

An average of one in 100 children in the United States has an autism spectrum disorder according to the Centers for Disease Control and Prevention. While over the last few years an increasing number of these children have begun to receive early intervention services, research shows that high quality and intensive intervention are critical for positive outcomes.

29 Mar 2010

Also in Global Health News: H1N1; USAID's Global Pulse; Rotavirus vaccine; Uzbek doctors; Zimbabwe development; Malaria vaccine

WHO flu chief Keiji Fukuda on Monday announced that a group of 29 independent scientists and public health experts has been formed to evaluate the response of the organization and national governments to the emergence of H1N1 (swine flu), the Associated Press reports. According to Fukuda, the committee will hold its first meeting April 12-14 (3/29).

29 Mar 2010

Eclipsys, Rothman partner to build Patient Condition Tracker software solution on Helios by Eclipsys platform

Following the momentum of launching an industry-defining open architecture platform, Eclipsys Corporation today announced a partnership with Rothman Healthcare Research to build its Patient Condition Tracker software solution on the Helios by Eclipsys™ platform.

29 Mar 2010

Unrestricted availability of food can trigger overconsumption and obesity

Some of the same brain mechanisms that fuel drug addiction in humans accompany the emergence of compulsive eating behaviors and the development of obesity in animals, according to research funded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health.

29 Mar 2010

Today's OpEds: The states' lawsuits, the need to trim health costs and industry winners

No sooner had President Obama signed comprehensive health care reform than the attorneys general of 14 states scurried to the federal courts to challenge the law. ... [they] are doing a disservice to their constituents by opposing Medicaid expansion and a mandate that everyone buy insurance, with subsidies for low- and middle-income people (3/28).

29 Mar 2010

Chakra Biotech completes MYR18.2m Series B investment round

Chakra Biotech Sdn Bhd, a Malaysian based Contract Research Organization, has completed a MYR18.2m Series B funding round. This brings total funding for the company to MYR20.0m. Malaysian Life Sciences Capital Fund Ltd. (MLSCF) and the Malaysian Technology Development Corporation Sdn Bhd (MTDC) participated in the round.

29 Mar 2010

As CMS nominee, Berwick would face changes and challenges

President Barack Obama will soon nominate Dr. Donald M. Berwick to "run Medicare and Medicaid, the programs that serve nearly one-third of all Americans, administration officials said Saturday," The New York Times reports.

29 Mar 2010

Closing Medicare drug gap helps Democrats sell reform

Kaiser Health News writer Christopher Weaver, in a story produced in collaboration with the Los Angeles Times, looks at the government's plan to close the Medicare prescription drug "doughnut hole."

29 Mar 2010

Interim data comparing Cervista HPV HR to Hybrid Capture 2 presented at 4th Biennial Meeting of AOGIN

Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced that interim data from the first large-scale independent evaluation of clinical performance of Cervista® HPV HR compared to Hybrid Capture 2 (hc2), were presented at the 4th Biennial Meeting of AOGIN (Asia-Oceanic Research Organization in Genital Infection and Neoplasia) in New Delhi, India on March 26-28, 2010.

29 Mar 2010

HealthCare.com launches new online resource for Medicare Supplemental information and quotes

HealthCare.com, Inc. the leader in online health insurance information and plan quotes, today announced the launch of MedicareSupplemental.com, a new website aimed to be the premier online resource for Medicare Supplemental information and quotes. The website provides extensive information to help consumers understand the complexities of Medicare Supplemental or "Medigap" coverage as well as a search tool to obtain quotes and connect with multiple brokers and agents.

29 Mar 2010

Ligand Pharmaceuticals' LGD-4033 SARM Phase I study data featured at 14th endocrinology congress

Ligand Pharmaceuticals Incorporated today announced that data from a Phase I study with its selective androgen receptor modulator (SARM) LGD-4033 was featured today in a poster presentation at the 14th International Congress of Endocrinology in Kyoto, Japan. This Phase I clinical trial was the first study in humans of LGD-4033, and evaluated the safety, tolerability and pharmacokinetic profiles of the molecule in a single escalating dose, double blind, placebo-controlled study in 48 healthy volunteers.

29 Mar 2010

Research News and Research

GenVec announces discontinuation of TNFerade PACT trial for pancreatic cancer

Conference on the actions of Vitamin D on human health

Researchers to study health literacy among Indigenous people living with cardiovascular disease

Shinseki tries to squelch rumors about health reform and Vets

Health industry will see more patients with reform; Physicians give mixed reviews

Democrats reflect on importance of reconciliation in health bill strategy

Alcon acquires right to market DUREZOL ophthalmic corticosteroid in U.S.

Industry groups, lobbying firms gain from health overhaul

Cutting off coverage? An examination of a case in California

National Institute of Mental Health awards two-year, $998,940 grant for autism research

Also in Global Health News: H1N1; USAID's Global Pulse; Rotavirus vaccine; Uzbek doctors; Zimbabwe development; Malaria vaccine

Eclipsys, Rothman partner to build Patient Condition Tracker software solution on Helios by Eclipsys platform

Unrestricted availability of food can trigger overconsumption and obesity

Today's OpEds: The states' lawsuits, the need to trim health costs and industry winners

Chakra Biotech completes MYR18.2m Series B investment round

As CMS nominee, Berwick would face changes and challenges

Closing Medicare drug gap helps Democrats sell reform

Interim data comparing Cervista HPV HR to Hybrid Capture 2 presented at 4th Biennial Meeting of AOGIN

HealthCare.com launches new online resource for Medicare Supplemental information and quotes

Ligand Pharmaceuticals' LGD-4033 SARM Phase I study data featured at 14th endocrinology congress

A guide to advancing biotherapeutic research eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence